[HTML][HTML] Clinicopathologic features of advanced squamous NSCLC

MA Socinski, C Obasaju, D Gandara, FR Hirsch… - Journal of Thoracic …, 2016 - Elsevier
Lung cancer remains the leading cause of cancer-related death worldwide. NSCLC
accounts for more than 85% of all lung cancers, and the prognosis for advanced-stage …

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

CA Jiménez-Ruiz, S Andreas… - European …, 2015 - publications.ersnet.org
Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary
tuberculosis are common pulmonary diseases that are caused or worsened by tobacco …

Smoking cessation after cancer diagnosis and enhanced therapy response: mechanisms and significance

S Chellappan - Current Oncology, 2022 - mdpi.com
The adverse effects of smoking on human health have been recognized for several
decades, especially in the context of cancer. The ability of tobacco smoke components …

[HTML][HTML] Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy

A Koch, H Fohlin, S Sörenson - Journal of thoracic oncology, 2009 - Elsevier
Hypothesis The objective of the study was to analyze if C-reactive protein (CRP) and
smoking status provide prognostic information in patients with advanced non-small cell lung …

Impact of smoking on lung cancer treatment effectiveness: a review

A Condoluci, C Mazzara, A Zoccoli, A Pezzuto… - Future …, 2016 - Taylor & Francis
Tobacco smoke contains more than 4000 detectable substances, such as polycyclic
aromatic hydrocarbons, nicotine, carbon monoxide and heavy metals, which are considered …

A bupropion smoking cessation clinical trial for cancer patients

RA Schnoll, E Martinez, KL Tatum, DM Weber… - Cancer Causes & …, 2010 - Springer
Objective Many cancer patients continue to smoke post diagnosis, yet there have been few
smoking cessation trials for this population. Depression, which is prevalent among cancer …

National cancer institute conference on treating tobacco dependence at cancer centers

G Morgan, RA Schnoll, CM Alfano, SE Evans… - Journal of Oncology …, 2011 - ascopubs.org
National Cancer Institute Conference on Treating Tobacco Dependence at Cancer Centers |
JCO Oncology Practice Skip to main content ASCO Publications Publications Journal of Clinical …

Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review

S Johal, R Hettle, J Carroll, P Maguire… - Journal of Thoracic …, 2021 - pmc.ncbi.nlm.nih.gov
Background Small-cell lung cancer (SCLC) accounts for 12–15% of lung cancers and is
associated with poor survival outcomes and high symptom burden. This study employed a …

Smoking cessation in lung cancer—achievable and effective

S Andreas, A Rittmeyer… - Deutsches Ärzteblatt …, 2013 - pmc.ncbi.nlm.nih.gov
Background Lung cancer is the leading cause of death from cancer in Germany. 90% of
cases are due to the inhalation of tobacco smoke. About 40% of patients with newly …

A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive‐disease small cell lung cancer

JY Han, KY Lim, SY Yu, T Yun, HT Kim, JS Lee - Cancer, 2011 - Wiley Online Library
BACKGROUND: The objective of this study was to investigate the efficacy of simvastatin in
combination with irinotecan and cisplatin in chemotherapy‐naive patients with extensive …